Sljedeći

Auto Play

Dr. Ai on Potential With Mogamulizumab in CTCL

3 Pogledi • 08/09/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, speaks to the relevance of mogamulizumab (Poteligeo) in treating Sezary syndrome, a rare and aggressive form of cutaneous T-cell lymphoma

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play